Advancing the economics of noncommunicable diseases in the Americas

Abstract

The global health burden of noncommunicable diseases (NCDs) is large and growing, as this group of diseases already accounts for 70% of total deaths. Global evidence indicates that the high health burden of NCDs translates into significant economic and social costs that threaten to diminish the quality of life of millions of individuals, impoverish families, jeopardize universal health coverage, and increase health disparities within and between countries. On the other hand, less than 2% of global donor health funding is directed towards preventing these diseases. Recognizing the trends in NCDs and the global evidence on their multidimensional costs and their potential to hamper development, Goal 3 of the Sustainable Development Goals includes a specific target (Target 3.4) of reducing mortality from NCDs by one-third by 2030.